Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2(+) ped...

por Chu, Yaya, Nayyar, Gaurav, Jiang, Susiyan, Rosenblum, Jeremy M., Soon-Shiong, Patrick, Safrit, Jeffrey T, Lee, Dean A., Cairo, Mitchell S.
Publicado 2021